US Patent Issued to MEMORIAL SLOAN KETTERING CANCER CENTER on March 18 for "Recombinant poxviruses for cancer immunotherapy" (New York Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,702, issued on March 18, was assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (New York).

"Recombinant poxviruses for cancer immunotherapy" was invented by Liang Deng (New York), Jedd Wolchok (New York), Stewart Shuman (New York), Taha Merghoub (New York), Ning Yang (New York), Yi Wang (New York), Gregory Mazo (New York), Peihong Dai (New York) and Weiyi Wang (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and compositions related to the treatment, prevention, and/or amelioration of cancer in a subject in need thereof. In particular aspects, the present technology relates to the use of genetically engineered ...